In the pathological process of myocardial fibrosis after MI, we first used human serum albumin-carried collagenase I (HSA-C) to degrade fibrotic collagen and reduce contrast agent retention in the cardiac fibrosis. The gene discussed is ALB; the disease is myocardial infarction.